SCHEMBL4594883

SCHEMBL4594883

CC(C)c1onc(-c2cccc(F)c2)c1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 1/20 0.47
GABRA5 P31644 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
GAA P10253 1/20 0.42
TSHR P16473 1/20 0.42
NR4A1 P22736 1/20 0.42
NR4A2 P43354 1/20 0.42
NR4A3 Q92570 1/20 0.42
PPARD Q03181 1/20 0.41
NR1H4 Q96RI1 3/20 0.41
HTR7 P34969 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KMO O15229 2/20 0.40
LIFR P42702 1/20 0.40
CSNK1D P48730 1/20 0.39
MAPK14 Q16539 1/20 0.39
TACR3 P29371 2/20 0.39
DHODH Q02127 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4594725 0.83 GPBAR1 (0.47) GPBAR1GABRA5SMN1; SMN2GAATSHR
SCHEMBL13733599 0.82 LMNA (0.49) GPBAR1GAATSHRNR4A1NR4A2
SCHEMBL4594713 0.82 GPBAR1 (0.62) GPBAR1GABRA5SMN1; SMN2GAATSHR
SCHEMBL4605073 0.78 NR1H4 (0.45) GPBAR1GABRA5NR1H4LIFR
SCHEMBL27918170 0.75 GPBAR1 (0.63) GPBAR1GABRA5GAATSHRALDH1A1
SCHEMBL11519685 0.75 KMT2A (0.51) GPBAR1SMN1; SMN2GAATSHRPPARD
SCHEMBL6081192 0.74 NR1H4 (0.59) GAATSHRPPARDNR1H4ALDH1A1
SCHEMBL2471876 0.74 GPBAR1 (0.62) GPBAR1GABRA5GAATSHRALDH1A1
SCHEMBL13733673 0.73 LMNA (0.72) GPBAR1GABRA5GAATSHRALDH1A1
SCHEMBL13501826 0.71 GPBAR1 (0.51) GPBAR1SMN1; SMN2GAATSHRPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101277952-A Isoxazole derivatives HOFFMANN LA ROCHE (CH) 2008-10-01 CN disclosed
EP-1937674-A1 ISOXAZOLE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-07-02 EP disclosed
US-7378435-B2 Aryl-isoxazole-4-carbonyl-indole-carboxylic acid amide derivatives HOFFMANN-LA ROCHE INC. (US) 2008-05-27 US disclosed
WO-2007042420-A1 ISOXAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-04-19 WO disclosed
US-20070082936-A1 Aryl-isoxazole-4-carbonyl-indole-carboxylic acid amide derivatives HOFFMANN-LA ROCHE INC. 2007-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070082936-A1 Aryl-isoxazole-4-carbonyl-indole-carboxylic acid amide derivatives GABRA5, GABRA4, CHRNA5 GPBAR1 244/4885GABRA5 1/4885SMN1; SMN2 2837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.